Suchergebnisse - "Kurti, Zsuzsanna"

PubPharm (73)

21

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

enthalten in: Quality of life research | 2018

von Rencz, F. | Lakatos, P. | Gulácsi, L. | +9

22

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

enthalten in: Quality of life research | 2018

von Rencz, F. | Lakatos, P. | Gulácsi, L. | +9

23

Progress with infliximab biosimilars for inflammatory bowel disease

enthalten in: Expert opinion on biological therapy | 2018

von Kurti, Z. | Gonczi, L. | Lakatos, P.

24

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary : a nationwide study based on the National Health Insurance Fund database

enthalten in: BMC gastroenterology | 2018

von Kurti, Z. | Ilias, A. | Gonczi, L. | +6

25

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

enthalten in: BMC gastroenterology | 2018

von Kurti, Z. | Ilias, A. | Gonczi, L. | +6

26

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

enthalten in: BMC gastroenterology | 2018

von Kurti, Z. | Ilias, A. | Gonczi, L. | +6

27

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Gonczi, L. | Kurti, Z. | Golovics, P. | +13

28

Can we Predict Disease Course with Clinical Factors?

enthalten in: Current drug targets | 2018

von Vegh, Z. | Kurti, Z. | Golovics, P. | +1

29

Can we Predict Disease Course with Clinical Factors?

enthalten in: Current drug targets | 2018

von Vegh, Z. | Kurti, Z. | Golovics, P. | +1

30

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

enthalten in: Inflammatory bowel diseases | 2017

von Gonczi, L. | Gecse, K. | Vegh, Z. | +23